Pharmacogenetic Risk Factors for Thiopurine-Induced Leukopenia in Patients with Inflammatory Bowel Disease. [PDF]
Boo EK, Yu J, Oh S, Cheon JH, Kim JH.
europepmc +1 more source
Structural and Functional Disruption of Thiopurine S‑Methyltransferase by the A80P Variant: A Simulation and Genotyping Study. [PDF]
Joshi K +4 more
europepmc +1 more source
Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study. [PDF]
Katabalo DM +7 more
europepmc +1 more source
Genetic and epigenetic underpinnings of biological aging: a multi-omics study integrating Mendelian randomization, spatial transcriptomics, and drug target discovery. [PDF]
Zhang C, Zhang J.
europepmc +1 more source
Impact of genetic polymorphisms on the response to transdermal fentanyl in cancer patients-a single-center, prospective, biological study. [PDF]
Angelini L +19 more
europepmc +1 more source
Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization. [PDF]
Chenchula S +20 more
europepmc +1 more source
Prognostic value of different sarcopenia assessment methods for mortality in patients with liver cirrhosis: a systematic review and meta-analysis. [PDF]
Xie W +6 more
europepmc +1 more source
Repositioning candidate gene approaches in the post-GWAS era: a clinical perspective from psychiatric pharmacogenetics. [PDF]
Pjevac M, Bon J, Dolžan V.
europepmc +1 more source
Pharmacogenomic landscape in Thailand: Array-based profiling and EMR-linked medication exposure. [PDF]
Pasookhush P +6 more
europepmc +1 more source
A PRISMA-guided systematic review of pharmacogenetic anticancer clinical trials registered on clinicaltrials.gov. [PDF]
Ashour AM, Alhayyan A, Alhayyan R.
europepmc +1 more source

